Belgium· BE-AMP-SAM116042-00

Impromen 2 mg/ml

A bromperidol product containing bromperidol, registered in Belgium by Eumedica Pharmaceuticals. The same ATC class is registered in 4 of our 19 countries.

ATC N05AD06

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedImpromen 2 mg/mlATCN05AD06REGISTER NO.BE-AMP-SAM116042-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Bromperidol is registered in 4 of 19 countries.

Countries holding a registration under ATC N05AD06 (bromperidol), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 1 of them publish a price we can compare per daily dose

Bromperidol · ATC N05AD06

4 / 19 countries

  • Belgiumprice
  • Germany
  • Japan
  • Netherlands
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Bromperidol
Manufacturer
Eumedica Pharmaceuticals
Country
Belgium (BE)
ATC code
N05AD06
ATC class
Bromperidol
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    0048017
    EUR 9.88
  • be_apb
    0709139

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Bromperidol in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bromperidol products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Germany · Impromen
  • Luxembourg · Impromen
  • Netherlands · Impromen, Impromen Decanoas

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c5154411-cedc-427f-973d-f071150bf8e4
GET /v1/drugs/c5154411-cedc-427f-973d-f071150bf8e4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oral drops, solution",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Impromen 2 mg/ml",
  "name_fr": "Impromen 2 mg/ml",
  "name_nl": "Impromen 2 mg/ml",
  "amp_code": "SAM116042-00",
  "strengths": [
    "2.0000",
    "2.4000",
    "0.5000",
    "0.0500"
  ],
  "pack_count": 2,
  "substances": [
    "Bromperidol",
    "Lactic Acid",
    "Methyl Parahydroxybenzoate",
    "Propyl Parahydroxybenzoate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Bromperidol",
  "authorisation_numbers": [
    "BE116042"
  ]
}

See everything about bromperidol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.